| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1038/S41417-019-0141-7 |
| P698 | PubMed publication ID | 31676843 |
| P2093 | author name string | Xu Li | |
| Shuai Zhen | |||
| P2860 | cites work | Lipid Nanoparticles for Ocular Gene Delivery | Q26823895 |
| Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells | Q27320024 | ||
| Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X. | Q27334548 | ||
| Newly Characterized Region of CP190 Associates with Microtubules and Mediates Proper Spindle Morphology in Drosophila Stem Cells | Q27336132 | ||
| Nanoparticle clearance is governed by Th1/Th2 immunity and strain background | Q30541000 | ||
| Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review | Q30656373 | ||
| Glomerular filtration is required for transfection of proximal tubular cells in the rat kidney following injection of DNA complexes into the renal artery | Q30842723 | ||
| CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model | Q33850663 | ||
| Screening and optimization of ligand conjugates for lysosomal targeting | Q35556045 | ||
| Characterization of the CRISPR/Cas subtype I-A system of the hyperthermophilic crenarchaeon Thermoproteus tenax | Q35943228 | ||
| Cationic compounds used in lipoplexes and polyplexes for gene delivery | Q35950617 | ||
| pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery | Q36137279 | ||
| pH and reduction dual-responsive dipeptide cationic lipids with α-tocopherol hydrophobic tail for efficient gene delivery | Q36284794 | ||
| Recombinant polymers for cancer gene therapy: a minireview | Q36303116 | ||
| Effect of surface properties on liposomal siRNA delivery | Q36421379 | ||
| PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery | Q36980520 | ||
| Nanoparticles evading the reticuloendothelial system: role of the supported bilayer | Q37376443 | ||
| Serum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics. | Q37451428 | ||
| Pathogen-mimetic stealth nanocarriers for drug delivery: a future possibility | Q37887120 | ||
| Exploiting CRISPR/Cas: interference mechanisms and applications. | Q38121774 | ||
| Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01. | Q38300347 | ||
| Multiplexed CRISPR/Cas9-mediated knockout of 19 Fanconi anemia pathway genes in zebrafish revealed their roles in growth, sexual development and fertility | Q61449222 | ||
| Liposomes as Gene Delivery Vectors for Human Placental Cells | Q61479716 | ||
| Influence of PEG coating on the biodistribution and tumor accumulation of pH-sensitive liposomes | Q61803080 | ||
| Targeted Transfection Using PEGylated Cationic Liposomes Directed Towards P-Selectin Increases siRNA Delivery into Activated Endothelial Cells | Q61812652 | ||
| Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration | Q63729526 | ||
| Implementation of a CRISPR-Based System for Gene Regulation in | Q64241486 | ||
| Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy. | Q64913711 | ||
| pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery. | Q64996190 | ||
| Cationic lipid binding to DNA: characterization of complex formation | Q71099257 | ||
| Visualizing dynamics of sub-hepatic distribution of nanoparticles using intravital multiphoton fluorescence microscopy | Q83837970 | ||
| Carbohydrate mediated drug delivery: synthesis and characterization of new lipid-conjugates | Q86100913 | ||
| Cationic lipid/DNA complexes manufactured by microfluidics and bulk self-assembly exhibit different transfection behavior | Q88590461 | ||
| Anionic pH-Sensitive Lipoplexes | Q88745273 | ||
| Pentaglycine lipid derivates - rp-HPLC analytics for bioorthogonal anchor molecules in targeted, multiple-composite liposomal drug delivery systems | Q88882355 | ||
| Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing | Q89232659 | ||
| PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy | Q90514540 | ||
| Improved Delivery of CRISPR/Cas9 System Using Magnetic Nanoparticles into Porcine Fibroblast | Q90601974 | ||
| Intracellular Delivery of His-Tagged Genome-Editing Proteins Enabled by Nitrilotriacetic Acid-Containing Lipidoid Nanoparticles | Q90631793 | ||
| Intracellular delivery and biodistribution study of CRISPR/Cas9 ribonucleoprotein loaded bioreducible lipidoid nanoparticles | Q90653915 | ||
| CRISPR RNA-guided autonomous delivery of Cas9 | Q90833369 | ||
| Multistage Delivery Nanoparticle Facilitates Efficient CRISPR/dCas9 Activation and Tumor Growth Suppression In Vivo | Q91047458 | ||
| Cationic cholesterol derivative efficiently delivers the genes: in silico and in vitro studies | Q91072599 | ||
| Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10 | Q91143094 | ||
| Lipoplex-Mediated Single-Cell Transfection via Droplet Microfluidics | Q91356120 | ||
| PEGylation of therapeutic oligonucletides: From linear to highly branched PEG architectures | Q91442183 | ||
| PEGylated Chitosan for Nonviral Aerosol and Mucosal Delivery of the CRISPR/Cas9 System in Vitro | Q91483971 | ||
| Surface PEGylation suppresses pulmonary effects of CuO in allergen-induced lung inflammation | Q91660612 | ||
| The final cut: Cas9 editing | Q91724050 | ||
| Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids | Q91950307 | ||
| Cationic lipoplexes for treatment of cancer stem cell-derived murine lung tumors | Q92112348 | ||
| A comprehensive search of functional sequence space using large mammalian display libraries created by gene editing | Q92152687 | ||
| Lipids for Nucleic Acid Delivery: Cationic or Neutral Lipoplexes, Synthesis, and Particle Formation | Q92153710 | ||
| Anti-PEG IgM Production via a PEGylated Nanocarrier System for Nucleic Acid Delivery | Q92153767 | ||
| Interaction of DNA with likely-charged lipid monolayers: An experimental study | Q92271012 | ||
| Design of a Novel PEGylated Liposomal Vector for Systemic Delivery of siRNA to Solid Tumors | Q92472881 | ||
| Gene Editing in Chronic Granulomatous Disease | Q92576783 | ||
| Effect of Cationic Lipid Type in Folate-PEG-Modified Cationic Liposomes on Folate Receptor-Mediated siRNA Transfection in Tumor Cells | Q93133161 | ||
| Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function | Q93199756 | ||
| Diversity of PEGylation methods of liposomes and their influence on RNA delivery | Q94321250 | ||
| Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives | Q46460581 | ||
| Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery | Q47274570 | ||
| Nonviral gene delivery vectors use syndecan-dependent transport mechanisms in filopodia to reach the cell surface | Q47310356 | ||
| Effect of Nanoparticle Surface Coating on Cell Toxicity and Mitochondria Uptake. | Q47698241 | ||
| Liposomal temozolomide drug delivery using convection enhanced delivery. | Q47823874 | ||
| Mixtures of hyaluronic acid and liposomes for drug delivery: Phase behavior, microstructure and mobility of liposomes. | Q47836077 | ||
| 'Nano-in-nano' hybrid liposomes increase target specificity and gene silencing efficiency in breast cancer induced SCID mice. | Q48769022 | ||
| Physicochemical properties of lipopeptide-based liposomes and their complexes with siRNA | Q50101624 | ||
| Oligonucleotide conjugated multi-functional adeno-associated viruses. | Q50333514 | ||
| Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung. | Q50519818 | ||
| Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages. | Q50672917 | ||
| Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo. | Q51020709 | ||
| Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy. | Q52373817 | ||
| How CRISPR is transforming drug discovery. | Q52430669 | ||
| Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteins. | Q52430855 | ||
| The Combinational Use of CRISPR/Cas9 and Targeted Toxin Technology Enables Efficient Isolation of Bi-Allelic Knockout Non-Human Mammalian Clones. | Q52431291 | ||
| The diffusion dynamics of PEGylated liposomes in the intact vitreous of the ex vivo porcine eye: A fluorescence correlation spectroscopy and biodistribution study. | Q52679540 | ||
| PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells. | Q55449441 | ||
| Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier | Q57283258 | ||
| Delivery of CRISPR-Cas9 into Mouse Zygotes by Electroporation | Q57785090 | ||
| CRISPR/Cas9-Based Gene Dropout Screens | Q57785201 | ||
| Effect of Monovalent Salt on Cationic Lipid Membranes As Revealed by Molecular Dynamics Simulations | Q58454528 | ||
| Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus | Q58574359 | ||
| Delivery of CRISPR/Cas9 by novel strategies for gene therapy | Q58612755 | ||
| A CRISPR-Cas9-triggered strand displacement amplification method for ultrasensitive DNA detection | Q59332865 | ||
| Long-Term Effects of In Vivo Genome Editing in the Mouse Retina Using Campylobacter jejuni Cas9 Expressed via Adeno-Associated Virus | Q59350237 | ||
| A lipid-based delivery system for antisense oligonucleotides derived from a hydrophobic complex. | Q38355830 | ||
| Design attributes of long-circulating polymeric drug delivery vehicles | Q38413301 | ||
| Liposomal Formulation of Monovalent Cholesteryl Cytofectins with Acyclic Head Groups and Gene Delivery: A Systematic Review | Q38561407 | ||
| Design of Microbubbles for Gene/Drug Delivery | Q38612534 | ||
| Cationic Liposomes Modified with Polyallylamine as a Gene Carrier: Preparation, Characterization and Transfection Efficiency Evaluation | Q38720627 | ||
| PEGylation potentiates hepatoma cell targeted liposome-mediated in vitro gene delivery via the asialoglycoprotein receptor | Q38722518 | ||
| pH-Sensitive PEGylated liposomes for delivery of an acidic dinitrobenzamide mustard prodrug: Pathways of internalization, cellular trafficking and cytotoxicity to cancer cells | Q38729789 | ||
| PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness. | Q38748266 | ||
| Cationic liposome-nucleic acid nanoparticle assemblies with applications in gene delivery and gene silencing | Q38764601 | ||
| Experimental design of a liposomal lipid system: A potential strategy for paclitaxel-based breast cancer treatment | Q38828971 | ||
| Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy. | Q38841311 | ||
| pH-sensitive polymer-liposome-based antigen delivery systems potentiated with interferon-γ gene lipoplex for efficient cancer immunotherapy. | Q38848217 | ||
| DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes | Q38859995 | ||
| Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains | Q38876767 | ||
| Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of ⁶⁴Cu-Au alloy nanoclusters | Q38952273 | ||
| Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma | Q38952654 | ||
| PEGylated galactosylated cationic liposomes for hepatocytic gene delivery | Q38968425 | ||
| Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499. | Q39018728 | ||
| In vitro assembly and activity of an archaeal CRISPR-Cas type I-A Cascade interference complex. | Q39094838 | ||
| A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity. | Q39778603 | ||
| Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA. | Q40153276 | ||
| Serum-resistant lipopolyplexes for gene delivery to liver tumour cells | Q40166830 | ||
| New multivalent cationic lipids reveal bell curve for transfection efficiency versus membrane charge density: lipid-DNA complexes for gene delivery. | Q40462997 | ||
| Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery | Q40498272 | ||
| A new triantennary galactose-targeted PEGylated gene carrier, characterization of its complex with DNA, and transfection of hepatoma cells. | Q40533532 | ||
| Electrostatically entrapped colistin liposomes for the treatment of Pseudomonas aeruginosa infection | Q40558076 | ||
| Targeting of lipid-protamine-DNA (LPD) lipopolyplexes using RGD motifs. | Q40608389 | ||
| Anionic/Zwitterionic Lipid-Based Gene Vectors of pDNA. | Q40642450 | ||
| Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. | Q40667906 | ||
| Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies | Q40980544 | ||
| Using CRISPR/Cas9-mediated gene editing to further explore growth and trade-off effects in myostatin-mutated F4 medaka (Oryzias latipes) | Q41198348 | ||
| Substrate generation for endonucleases of CRISPR/cas systems | Q41461432 | ||
| Pegylation of poly(γ-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats | Q41888204 | ||
| pH-sensitive, cationic liposomes: a new synthetic virus-like vector | Q41930572 | ||
| Mutations in the Spliceosome Component CWC27 Cause Retinal Degeneration with or without Additional Developmental Anomalies | Q42038690 | ||
| The Rice AAA-ATPase OsFIGNL1 Is Essential for Male Meiosis | Q42287508 | ||
| A pH-sensitive polymer that enhances cationic lipid-mediated gene transfer | Q42823523 | ||
| Pegylated immuno-lipopolyplexes: A novel non-viral gene delivery system for liver cancer therapy | Q43167032 | ||
| Colloidal stability of nano-sized particles in the peritoneal fluid: towards optimizing drug delivery systems for intraperitoneal therapy | Q43756230 | ||
| Peptide-mediated gene transfer of cationic lipid/plasmid DNA complexes to endothelial cells | Q45125458 | ||
| Universal concept for the implementation of a single cleavable unit at tunable position in functional poly(ethylene glycol)s | Q45739287 | ||
| Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis | Q45763061 | ||
| Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy | Q45863480 | ||
| Integrated microfluidic devices for the synthesis of nanoscale liposomes and lipoplexes | Q45864267 | ||
| Anionic Lipid, pH-Sensitive Liposome-Gold Nanoparticle Hybrids for Gene Delivery - Quantitative Research of the Mechanism | Q45872081 | ||
| Binding and interstitial penetration of liposomes within avascular tumor spheroids. | Q45878088 | ||
| PR_b-targeted PEGylated liposomes for prostate cancer therapy. | Q46293279 | ||
| P921 | main subject | Cas9 | Q16965677 |
| CRISPR | Q412563 | ||
| CRISPR-Cas method | Q17310682 | ||
| P577 | publication date | 2019-11-02 | |
| P1433 | published in | Cancer Gene Therapy | Q15763088 |
| P1476 | title | Liposomal delivery of CRISPR/Cas9 |
| Q90163228 | Gene Therapy in Cancer Treatment: Why Go Nano? | cites work | P2860 |
Search more.